![]() |
市場調查報告書
商品編碼
1635549
全球神經內視鏡市場 - 市場規模(依細分)、佔有率、監管、償付、使用單位、預測(~2036年)Neuroendoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告對全球神經內視鏡市場進行了深入分析,提供了各地區市場規模、主要趨勢、創新產品和技術以及競爭格局的資訊。
市場模型的主要組成如下:
已上市的神經內視鏡和不斷發展的競爭格局
全球、區域和國家層面的市場洞察
掌握包括醫療保健系統概況在內的真實全局,加深對市場的了解。此外,市場進入部分提供有關償付政策和監管環境的資訊,可以更深入地了解市場動態。
目標公司
Neuroendoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
Neuroendoscopes are endoscopes which are used for treatment of conditions of the central nervous system. Disposable devices and accessories are not considered in this segment. Neuroendoscopes are sometimes used to assist with certain steps of microscope surgery to facilitate visualization around corners and avoid unnecessary restriction and skull base drilling e.g. in aneurysm surgery. Neuroendoscopy is used to treat a variety of diseases including: hydrocephalus; craniosynostosis; intracranial cysts; hypothalamic hamartoma; degenerative spine disease; and brain cancers such as periventricular, intraventricular and skull base tumors.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Neuroendoscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - B. Braun Melsungen AG, KARL STORZ SE & Co KG, Adeor Medical AG, Machida Endoscope Co Ltd, Clearmind Biomedical Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -